Key facts
- It has raised $6.2M; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include CVX Ventures, Chalmers Ventures, Swedish-American Chamber of Commerce - New York (SACCNY), Life Science Invest, Sahlgrenska Science Park — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Anyo Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Anyo Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anyo Labs
Developer of a drug discovery platform designed to accelerate the development of new medicines. The company offers a screening and scoring tool that accelerates and reduces risk with expert support in the early stages of research, enabling healthcare industry clients to cut down on the time and resources required to bring new drugs to market.
- Sector
- Healthcare
- HQ
- Gothenburg, Sweden
- Founded
- 2022
- Employees
- 7
- Website
- anyolabs.com/
- Ownership
- Privately Held (backing)
Anyo Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anyo Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anyo Labs in its N-PORT filings yet. We sweep new filings monthly.